ImmunoPrism Protocol Published in Peer-Reviewed Journal of Visualized Experiments
Cambridge, MA – March 10, 2020 – Video methods for the molecular protocol associated with the Cofactor Genomics ImmunoPrism® Assay are now published in the Journal of Visualized Experiments. The peer-reviewed publication, entitled “Predictive Immune Modeling of Solid Tumors,” ...
New Study Shows Predictive Immune Modeling from Cofactor Genomics is Superior to PD-L1 Assays in Predicting Patient Response to Anti-PD-1 Therapy
SCOTTSDALE, Ariz. -- February 27, 2020 -- Cofactor Genomics, the company bridging the precision medicine gap with Predictive Immune Modeling, today announced preliminary results from a collaborative study with Washington University School of Medicine in St. Louis, which demons...
Cofactor Genomics Opens Early Access to New T Cell Exhaustion Models through Predictive Immune Modeling Platform
San Francisco, CA -- November 6, 2019 -- Cofactor Genomics, leaders in RNA-based technologies and diagnostics, announced today they will provide early access to a new feature in their Predictive Immune Modeling platform which enables cell-state characterization within FFPE tis...